Skip to content
This project seeks to provide evidence for the hypothesis that regulating serotonin metabolism will reduce impulsivity and thus lead to improved offending outcomes.
Using a randomised control trial of selective serotonin reuptake inhibitors (SSRIs) versus placebo in a sample of community-based offenders, the project will aim to establish if SSRIs are beneficial in reducing impulsive, violent behaviour.
The project is based on the rationale that serotonergic dysfunction in the brain is linked to impulsive behaviour, and impulsivity is linked to offending behaviour, including violent offending. SSRIs are a class of antidepressants that aim to regulate serotonin metabolism in the brain. It is hypothesised that regulating serotonin metabolism will reduce impulsivity and lead to improved offending outcomes.
Abstract adapted from The Kirby Institute for Infection and Immunity
Professor and Program Head
Justice health research program
The Kirby Institute for Infection and Immunity
University of New South Wales
Corner Boundary and West Streets
Darlinghurst NSW 2010
Ph: (02) 9289 2928